Clinical Trial Update: Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates termination of a study evaluating long-acting growth hormone somavaratan (VRS-317) in pre-pubertal Japanese children with grow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders
• Growth Hormone Deficiency

Drugs mentioned

• Somavaratan (somavaratan)

Snippet

Sponsor: Versartis Inc. | Conditions: Pediatric Growth Hormone Deficiency, Growth Disorders | Phase 2, Phase 3 | Status: TERMINATED